Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 10 11 12 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bruker Corporation. (2/14/18). "Press Release: The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology". Billerica, MA. 2018-02-14
Recipharm AB. (2/14/18). "Press Release: Recipharm Appoints President Development Services to Drive End to End Offering". 2018-02-14
Affimed N.V.. (2/13/18). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. 2018-02-13
Gilde Healthcare Partners. (2/13/18). "Press Release: Gilde Healthcare Company RAD-x Continues Buy & Build with Acquisition of Swiss Medical Imaging Centers". Utrecht. 2018-02-13
Sciomics GmbH. (2/12/18). "Press Release: Sciomics Participates in Collaborative Clinical Trials for the Treatment of Metaphyseal Chondrodysplasia Type Schmid (MCDS)". Heidelberg. 2018-02-12
Affimed N.V.. (2/12/18). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. 2018-02-12
Lonza Group AG. (2/12/18). "Press Release: Lonza Expands Cell-Culture Portfolio with Quasi Vivo System". Basel. 2018-02-12
Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA. 2018-02-09
Boehringer Ingelheim. (2/9/18). "Press Release: Boehringer Ingelheim Refocuses PDE9 Inhibition Brain Research on Schizophrenia Following Results from Phase II Alzheimer’s Trials". Ingelheim. 2018-02-09
Bruker Corporation. (2/8/18). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2017 Financial Results". Billerica, MA. 2018-02-08
Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA. 2018-02-08
Genedata AG. (2/8/18). "Press Release: Genedata Bioprocess Licensed to Pfizer Inc.". Basel. 2018-02-08
Lonza Group Ltd.. (2/8/18). "Press Release: Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines". Basel & South San Francisco, CA. 2018-02-08
University of Bayreuth. (2/8/18). "Press Release: Innovative Research Infrastructure with a Global Reputation. The Northern Bavarian NRM Centre Repositions Itself". 2018-02-08
c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company". 2018-02-08
Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. 2018-02-07
Addex Therapeutics S.A.. (2/7/18). "Press Release: Addex Appoints Jean-Philippe Rocher as Co-Head of Discovery and Member of the Executive Management". Geneva. 2018-02-07
Analytik Jena AG. (2/7/18). "Press Release: Laboratory Automation Solution Designed to Boost Productivity Showcased at SLAS 2018". San Diego, CA & Jena. 2018-02-07
Lonza Group Ltd.. (2/7/18). "Press Release: Lonza Partners with Prolog Ventures to Establish VC Fund to Invest in Consumer Health and Wellness Startups". Basel. 2018-02-07
Sanofi S.A.. (2/7/18). "Press Release: Sanofi Delivers 2017 Business EPS(1) in Line with Guidance". Paris. 2018-02-07
ProBioGen AG. (2/7/18). "Press Release: ProBioGen and Teva Sign License Agreement on Human Artificial Lymph Node Technology". Berlin. 2018-02-07
ImmunoQure AG. (2/6/18). "Press Release: Servier and ImmunoQure AG Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody". Paris & Düsseldorf. 2018-02-06
Genedata AG. (2/6/18). "Press Release: Genedata Announces New Solution for NGS-Based Biosafety Assessment". Basel. 2018-02-06
Idorsia Ltd.. (2/6/18). "Press Release: Idorsia Announces Financial Results for 2017 – Company Off to a Great Start – 4 Compounds to Enter Phase 3 Development". Allschwil. 2018-02-06
InflaRx N.V.. (2/6/18). "Press Release: InflaRx Announces Appointment of Tony Gibney to Its Board of Directors". Jena. 2018-02-06
Selvita S.A.. (2/6/18). "Press Release: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer". Kraków. 2018-02-06
Sophia Genetics S.A.. (2/6/18). "Press Release: Sophia Genetics Announces CE-IVD Marking of Its Genomic Test for Leukemia Detection". Lausanne. 2018-02-06
Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku. 2018-02-05
Addex Therapeutics S.A.. (2/5/18). "Press Release: Addex Provides Key Financial Indicators and Trading Update. Cash Position of CHF6.5 million as of 31 January 2018". Geneva. 2018-02-05
SGS S.A.. (2/2/18). "Press Release: SGS Acquires TraitGenetics GmbH, Germany". 2018-02-02
Genedata AG. (2/2/18). "Press Release: Genedata Profiler Powers Major Breakthroughs in Early Prediction of Breast and Ovarian Cancer". Basel. 2018-02-02
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-02-01
Medigene AG. (2/1/18). "Press Release: Medigene Strengthens Its Patent Portfolio with a US Patent on a Tagged TCR". Planegg. 2018-02-01
Lab Automation Network (LAN). (2/1/18). "Press Release: Cytosurge AG and Lab Automation Network Announce Partnership for Automated Single-cell Biology Applications". 2018-02-01
Life Science Inkubator GmbH. (2/1/18). "Press Release: Life Science Inkubator (LSI) Bonn for the First Time Supports Pharma Industry Spin-out". 2018-02-01
Miltenyi Biotec GmbH. (2/1/18). "Press Release: Cancer Coaching for the Immune System. Novel Cell Therapy Will Teach Immune Cells How to Fight Cancer". Teterow. 2018-02-01
Arnold & Porter LLP. (2/1/18). "Press Release: Announcing Arnold & Porter". 2018-02-01
Affimed N.V.. (2/1/18). "Press Release: Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas". Heidelberg. 2018-02-01
Qiagen N.V.. (1/31/18). "Press Release: Qiagen Enters into Agreement to Acquire STAT-Dx, Plans to Launch a Next-generation, Fully Integrated Multiplex Platform for Syndromic Disease Testing". Germantown, MD & Hilden. 2018-01-31
Genedata AG. (1/31/18). "Press Release: Genedata Announces Genedata Screener for Massive Mechanistic Analysis". Basel. 2018-01-31
Analytik Jena AG. (1/31/18). "Press Release: SLAS 2018 — Modular Liquid Handling System CyBio FeliX Automates New Process for Nucleic Acid Extraction". Jena. 2018-01-31
Lonza Group AG. (1/31/18). "Press Release: Lonza Reports Record-breaking Full-year Results with Double-digit Lonza Standalone Sales Growth and More than 26% CORE EBIT Growth in a Major Transformational Year". Basel. 2018-01-31
Sanofi S.A.. (1/31/18). "Press Release: Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment". Paris & Geneva. 2018-01-31
AiCuris Anti-infective Cures GmbH. (1/31/18). "Press Release: Approval of MSD’s Prevymis (letermovir) by the European Commission Triggers the Next EUR 30 Million Milestone Payment for AiCuris". Wuppertal. 2018-01-31
Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena. 2018-01-31
Rentschler Biopharma SE. (1/31/18). "Press Release: Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer". Laupheim. 2018-01-31
Helsinn Healthcare S.A.. (1/30/18). "Press Release: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement". Lugano. 2018-01-30
Creathor Venture Management GmbH. (1/30/18). "Press Release: Creathor Invests in E-Health Platform »Humanoo«". Berlin & Bad Homburg v.d.H.. 2018-01-30
BaseLaunch (BaselArea.swiss). (1/30/18). "Press Release: BaseLaunch up to a Solid Phase II Start". Basel. 2018-01-30
Sanofi S.A.. (1/29/18). "Press Release: Sanofi to Acquire Ablynx for €3.9 Billion". Paris & Ghent. 2018-01-29
Merck KGaA. (1/26/18). "Press Release: Dirk Toepfer Joins Merck as Chief Information Officer". Darmstadt. 2018-01-26
Endress+Hauser AG. (1/26/18). "Press Release: Further Growth for Endress+Hauser in China. Third Plant Inaugurated in Suzhou". 2018-01-26
Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. 2018-01-26
Santhera Pharmaceuticals Holding AG. (1/26/18). "Press Release: Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone in Duchenne Muscular Dystrophy". Liestal. 2018-01-26
Roche. (1/26/18). "Press Release: CHMP Recommends EU Approval of Roche’s Hemlibra for People with Haemophilia A with Inhibitors". Basel. 2018-01-26
Illumina, Inc.. (1/26/18). "Press Release: Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2018-01-26
ThromboGenics N.V.. (1/26/18). "Press Release: Novartis Pharma AG Holding 5.69% of ThromboGenics Equity Capital". Leuven. 2018-01-26
Clariant. (1/25/18). "Press Release: SABIC Acquires 24.99% Stake in Clariant. SABIC Acquires Stakes Previously Held by 40 North and Corvex Management". Muttenz. 2018-01-25
PerkinElmer, Inc.. (1/25/18). "Press Release: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017". Waltham, MA. 2018-01-25
Topas Therapeutics GmbH. (1/25/18). "Press Release: Topas Therapeutics Serves as Exclusive Translational Partner for Collaborative Research Center Focused on Liver Inflammation at University Medical Center Hamburg-Eppendorf". Hamburg. 2018-01-25
Novartis AG. (1/24/18). "Press Release: Novartis Delivered Good Operational Performance and Landmark Innovation in 2017, Entering Our Next Growth Phase". Basel. 2018-01-24
Novartis AG. (1/24/18). "Press Release: Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss". Basel. 2018-01-24
ImmuPharma plc. (1/24/18). "Press Release: Successful Placing to Raise £10 Million". 2018-01-24
Qlucore AB. (1/24/18). "Press Release: Enhanced Collaboration between Qlucore and Nebion to Help Biologists Get More Out of Their Data Analysis". 2018-01-24
CureVac AG. (1/24/18). "Press Release: CureVac Expands Intellectual Property Position that Significantly Improves Protein Expression for its mRNA-Based Vaccines and Therapeutics". Tübingen. 2018-01-24
Genedata AG. (1/24/18). "Press Release: Genedata, HighRes Biosolutions, and Titian Software Collaborate for Automated End-to-End Screening Solution". Basel, Beverly, CA & London. 2018-01-24
Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. 2018-01-24
Qiagen N.V.. (1/23/18). "Press Release: Qiagen Receives FDA Clearance for First-ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms". Hilden & Germantown, MD. 2018-01-23
High-Tech Gründerfonds Management GmbH. (1/23/18). "Press Release: Dräger Invests in HTGF III". 2018-01-23
BCNP Consultants GmbH. (1/22/18). "Press Release: 23rd February Chemistry Industry Innovators from 27 Countries Will Meet at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-01-22
Celgene Corporation. (1/22/18). "Press Release: Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ & Seattle, WA. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Completes Tender Offer for Advanced Accelerator Applications S.A. and Announces Commencement of Subsequent Offering Period". Basel. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Reports Erenumab Met All Primary and Secondary Endpoints in Unique Phase IIIb Study in Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments". Basel. 2018-01-22
Genmab A/S. (1/22/18). "Press Release: Genmab Announces Novartis' Intention to Transition Arzerra (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets". Copenhagen. 2018-01-22
Sanofi S.A.. (1/19/18). "Press Release: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee". Paris. 2018-01-19
Biotest AG. (1/19/18). "Press Release: All Conditions Met for Creat Takeover of Biotest". Dreieich. 2018-01-19
Qiagen N.V.. (1/18/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-01-18
Inositec AG. (1/18/18). "Press Release: Inositec AG Appoints Dr Frits van Alphen as Chief Medical Officer". Zurich. 2018-01-18
ERS Genomics Ltd.. (1/18/18). "Press Release: ERS Genomics Responds to Revocation of Broad Institute European Patent". Dublin. 2018-01-18
Novartis AG. (1/18/18). "Press Release: Sandoz Announces Exclusive Global Collaboration with Biocon on Next-generation Biosimilars". Holzkirchen. 2018-01-18
Selexis S.A.. (1/17/18). "Press Release: Selexis SA Appoints Alberto Garotti as Chief Financial Officer". Geneva. 2018-01-17
Synpromics Ltd.. (1/17/18). "Press Release: Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development. Company Establishes U.S. Subsidiary to Expand Operations". Edinburgh. 2018-01-17
Novartis AG. (1/17/18). "Press Release: Novartis Granted US FDA Priority Review for Kymriah (tisagenlecleucel), formerly CTL019, for Adults with r/r DLBCL". Basel. 2018-01-17
Helmholtz-Zentrum München. (1/17/18). "Press Release: Innovative Antibody Production. Helmholtz Association Funding Spin-off". 2018-01-17
Immatics Biotechnologies GmbH. (1/17/18). "Press Release: Immatics Appoints Thomas Ulmer as Chief Financial Officer". Tübingen & Houston, TX. 2018-01-17
Novartis AG. (1/16/18). "Press Release: Novartis New Data Reinforces Superiority of Cosentyx versus Stelara in Achieving Skin Clearance for Psoriasis Patients". Basel. 2018-01-16
Novartis AG. (1/16/18). "Press Release: Sandoz Regulatory Submission for Proposed Biosimilar Adalimumab Accepted by FDA". Holzkirchen. 2018-01-16
Owkin. (1/16/18). "Press Release: Owkin Closes $11 Million Series A Financing Round". New York, NY. 2018-01-16
Merck KGaA. (1/16/18). "Press Release: Merck Presents Data on Bifunctional Immunotherapy M7824 at ASCO 2018 Gastrointestinal Cancers Symposium". Darmstadt. 2018-01-16
BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz. 2018-01-15
Roche. (1/12/18). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in the European Union for Relapsing Forms of Multiple Sclerosis and Primary Progressive Multiple Sclerosis". Basel. 2018-01-12
Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". 2018-01-11
Novartis AG. (1/11/18). "Press Release: Novartis Appoints Elizabeth Barrett as Oncology Head". Basel. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer". Menlo Park, CA. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate on a Novel Immuno-Oncology Combination for Leukemia and Bladder Cancer". Menlo Park, CA. 2018-01-11
Immunic AG. (1/11/18). "Press Release: FDA Approves IND for Immunic Therapeutics’ IMU-838 to Proceed with Phase 2 Study in Ulcerative Colitis". Planegg-Martinsried. 2018-01-11
Gilde Healthcare Partners. (1/11/18). "Press Release: Gilde Healthcare Opens Office in Frankfurt Germany". Utrecht & Frankfurt a. M.. 2018-01-11
Genedata AG. (1/11/18). "Press Release: Genedata Announces New Solution for CRISPR Data Management and Analysis". Basel. 2018-01-11
Sophia Genetics S.A.. (1/11/18). "Press Release: Sophia Genetics Appoints Valentin Matillon as New Chief Financial Officer". St. Sulpice. 2018-01-11
Enamine Ltd.. (1/10/18). "Press Release: Enamine Supplies DSI Poised Fragment and Analogue Libraries to Diamond Light Source XChem Facility and SGC Oxford Screening Efforts". Kiev & Oxford. 2018-01-10
next pagenext page 1 2 3 ... 10 11 12 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top